Your browser doesn't support javascript.
loading
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.
Brouwer, Philip J M; Antanasijevic, Aleksandar; de Gast, Marlon; Allen, Joel D; Bijl, Tom P L; Yasmeen, Anila; Ravichandran, Rashmi; Burger, Judith A; Ozorowski, Gabriel; Torres, Jonathan L; LaBranche, Celia; Montefiori, David C; Ringe, Rajesh P; van Gils, Marit J; Moore, John P; Klasse, Per Johan; Crispin, Max; King, Neil P; Ward, Andrew B; Sanders, Rogier W.
Affiliation
  • Brouwer PJM; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Antanasijevic A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • de Gast M; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Allen JD; School of Biological Sciences, University of Southampton, Southampton, UK.
  • Bijl TPL; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Yasmeen A; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • Ravichandran R; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Burger JA; Institute for Protein Design, University of Washington, Seattle, WA, USA.
  • Ozorowski G; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • LaBranche C; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Ringe RP; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • van Gils MJ; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • Moore JP; Institute of Microbial Technology, Chandigarh, India.
  • Klasse PJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Crispin M; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • King NP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • Ward AB; School of Biological Sciences, University of Southampton, Southampton, UK.
  • Sanders RW; Department of Biochemistry, University of Washington, Seattle, WA, USA. neil@ipd.uw.edu.
NPJ Vaccines ; 6(1): 24, 2021 Feb 09.
Article in En | MEDLINE | ID: mdl-33563983
ABSTRACT
The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Vaccines Year: 2021 Document type: Article Affiliation country: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Vaccines Year: 2021 Document type: Article Affiliation country: Países Bajos